Myriad Applauds New ACOG Guidelines For Hereditary Breast And Ovarian Cancer
Myriad Genetics, Inc. (NASDAQ: MYGN) announced its support of The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 103, dated April 2009, which sets forth ACOG's clinical management guidelines for obstetricians and gynecologists.
More... |
All times are GMT -7. The time now is 08:10 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021